Drivers of Innovation in Pediatric Nutrition

66th Nestlé Nutrition Institute Workshop, Pediatric Program, Sanya, November 2009

Editor(s): Koletzko, B. (Munich)
Koletzko, S. (Munich)
Ruemmele, F. (Paris)

Determinants of Innovative Progress

Technological Progress as a Driver of Innovation in Infant Foods

Ferruzzi M.G.a,b · Neilson A.P.a

Author affiliations

Departments of aPediatrics, bOtolaryngology and cMicrobiology and d2nd Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan

Related Articles for ""

Koletzko B, Koletzko S, Ruemmele F (eds): Drivers of Innovation in Pediatric Nutrition. Nestlé Nutr Inst Workshop Ser Pediatr Program, vol 66, pp 81–95, Nestec Ltd., Vevey/S. Karger AG, Basel, © 2010

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Complete book

  • Immediate access to all parts of this book
  • Cover-to-cover formats may be available
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restriction for personal use
read more

Pricing depends on hard-cover price


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Determinants of Innovative Progress

Published online: July 21, 2010
Cover Date: 2010

Number of Print Pages: 15
Number of Figures: 0
Number of Tables: 0

ISBN: 978-3-8055-9454-7 (Print)
eISBN: 978-3-8055-9455-4 (Online)

Abstract

Advances in nutrition and food sciences are interrelated components of the innovative framework for infant formula and foods. While nutrition science continues to define the composition and functionality of human milk as a reference, food ingredient, formulation and processing technologies facilitate the design and delivery of nutritional and functional concepts to infant products. Expanding knowledge of both nutritive and non-nutritive components of human milk and their functionality guides selection and development of novel ingredient, formulation and processing methods to generate enhanced infant products targeting benefits including healthy growth, development as well as protection of health through the life cycle. In this chapter, identification and application of select novel ingredients/technologies will be discussed in the context of how these technological advancements have stimulated innovation in infant foods. Special focus will be given to advancements in protein technologies, as well as bioactive long-chain polyunsaturated fatty acids, prebiotics, probiotics that have allowed infant formula composition, and more critically functionality, to more closely align with that of human milk.

© 2010 S. Karger AG, Basel




Related Articles:


References

  1. Food and Nutrition Board, Committee on the Evaluation of the Addition of Ingredients New to Infant Formula: Infant Formula: Evaluating the Safety of New Ingredients. Washington, The National Academies Press, 2004;
  2. Rai D, Larson B: Driving research in infant and children's nutrition: a perspective on industry. Am J Clin Nutr 2009;89:1530S-1532S
  3. Picciano MF: Nutrient composition of human milk. Pediatr Clin North Am 2001;48:53-67
  4. Koletzko B, Baker S, Cleghorn G, et al: Global standard for the composition of infant formula: recommendations of an ESPGHAN coordinated international expert group. J Pediatr Gastroenterol Nutr 2005;41:584-599
  5. Fleith M, Clandinin MT: Dietary PUFA for preterm and term infants: review of clinical studies. Crit Rev Food Sci Nutr 2005;45:205-229
  6. Zimmer JP, Hammond BR: Possible influences of lutein and zeaxanthin on the developing retina. Clin Ophthalmol 2007;1:25-35
  7. Joeckel RJ, Phillips SK: Overview of infant and pediatric formulas. Nutr Clin Pract 2009;24:356-362
  8. Tomita M, Wakabayashi H, Yamauchi K, et al: Bovine lactoferrin and lactoferricin derived from milk: production and applications. Biochem Cell Biol 2002;80:109-112
  9. Lönnerdal B: Nutritional roles of lactoferrin. Curr Opin Clin Nutr Metab Care 2009;12:293-297
  10. Satué-Gracia MT, Frankel EN, Rangavajhyala N, German JB: Lactoferrin in infant formulas: effect on oxidation. J Agric Food Chem 2000;48:4984-4990
  11. Arterburn LM, Hall EB, Oken H: Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 2006;83:1467S-1476S
  12. Koletzko B, Lien E, Agostoni C, et al: World Association of Perinatal Medicine Dietary Guidelines Working Group. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med 2008;36:5-14
  13. Koo WW: Efficacy and safety of docosahexaenoic acid and arachidonic acid addition to infant formulas: can one buy better vision and intelligence?. J Am Coll Nutr 2003;22:101-107
  14. Bode L: Recent advances on structure, metabolism, and function of human milk oligosaccharides. J Nutr 2006;136:2127-2130
  15. Espinosa RM, Taméz M, Prieto P: Efforts to emulate human milk oligosaccharides. Br J Nutr 2007;98:S74-S79
  16. Osborn DA, Sinn JK: Prebiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst Rev 2007;CD006474
  17. Fuller R: Probiotics in human medicine. Gut 1991;32:439-442
  18. Parracho H, McCartney AL, Gibson GR: Probiotics and prebiotics in infant nutrition. Proc Nutr Soc 2007;66:405-411
  19. Osborn DA, Sinn JK: Probiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst Rev 2007;CD006475
  20. Martín R, Heilig GH, Zoetendal EG, et al: Diversity of the Lactobacillus group in breast milk and vagina of healthy women and potential role in the colonization of the infant gut. J Appl Microbiol 2007;103:2638-2644
  21. Lara-Villoslada F, Sierra S, Díaz-Ropero MP, et al: Safety assessment of Lactobacillus fermentum CECT5716, a probiotic strain isolated from human milk. J Dairy Res 2009;76:216-221
  22. Stringham JM, Hammond BR, Jr: Dietary lutein and zeaxanthin: possible effects on visual function. Nutr Rev 2005;63:59-64
  23. Canfield LM, Clandinin MT, Davies DP, et al: Multinational study of major breast milk carotenoids of healthy mothers. Eur J Nutr 2003;42:133-141
  24. Schweigert FJ, Bathe K, Chen F, et al: Effect of the stage of lactation in humans on carotenoid levels in milk, blood plasma and plasma lipoprotein fractions. Eur J Nutr 2004;43:39-44
  25. Jewell VC, Mayes CB, Tubman TR, et al: A comparison of lutein and zeaxanthin concentrations in formula and human milk samples from Northern Ireland mothers. Eur J Clin Nutr 2004;58:90-97
  26. Barrett-Reis B: Method of reducing the risk of retinopathy of prematurity in preterm infants. US Patent Application number: 11/646,671. Publication number: US 2007/0166354 A1. Filing dateDec 28, 2006;
  27. Singhal A, Cole TJ, Fewtrell M, Lucas A: Breastmilk feeding and lipoprotein profile in adolescents born preterm: follow-up of a prospective randomised study. Lancet 2004;363:1571-1578
  28. Parikh NI, Hwang SJ, Ingelsson E, Benjamin EJ, et al: Breastfeeding in infancy and adult cardiovascular disease risk factors. Am J Med 2009;122:656-663
  29. Mennella JA, Forestell CA, Morgan LK, Beauchamp GK: Early milk feeding influences taste acceptance and liking during infancy. Am J Clin Nutr 2009;90:780S-788S
  30. Lönnerdal B: Personalizing nutrient intakes of formula-fed infants: Breast milk as a model. Bier DM, German JB, Lönnerdal B: Personalized Nutrition for the Diverse Needs of Infants and Children. Nestlé Nutr Workshop Ser Pediatr Program Vevey, Nestec/ Basel, Karger, 2008;62:189-203

Article / Publication Details

First-Page Preview
Abstract of Determinants of Innovative Progress

Published online: July 21, 2010
Cover Date: 2010

Number of Print Pages: 15
Number of Figures: 0
Number of Tables: 0

ISBN: 978-3-8055-9454-7 (Print)
eISBN: 978-3-8055-9455-4 (Online)


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP